News
Events at the Marathon in Boston
Cure Alzheimer’s Fund is saddened by the terror attack at the Boston Marathon. Our hearts go out to all who have been affected by these horrible incidents. We are so proud of the runners, all those behind the scenes and all who supported our marathon running team this year. We are happy to report that none of our team was near enough to the blasts to be injured. We want to say thank you to those who supported our marathon team. Also thanks to the many of you who have expressed concern.
Global Program on Alzheimer’s Stem Cells to Accelerate Discovery of Causes and Cures for the Most Common Dementia: Effort Described as the Search for ‘Alzheimer’s Holy Grail’
Washington—Uncovering the cure for Alzheimer’s disease at a rate never before possible and giving individuals a way to better understand their chances of facing Alzheimer’s are the outcomes of new advances in stem cell research from the Cure Alzheimer’s Fund (CAF) Stem Cell Research Consortium that use skin samples to identify potential therapies for the disease.
NATIONAL PLAN TO ADDRESS ALZHEIMER’S DISEASE
Cure Alzheimer’s Fund is grateful to President Obama for the Administration’s continued commitment to curing Alzheimer’s disease. With the implementation of the first ever National Plan To End Alzheimer’s Disease to which Cure Alzheimer’s Fund was a contributor , and his specific targeting of the disease last night in the ‘State of the Union’ address, President Obama has highlighted a national resolve to defeat this disease.
For Second Consecutive Year, Cure Alzheimer’s Fund Receives Highest Rating from Charity Navigator
Cure Alzheimer’s Fund has been awarded the highest rating for sound fiscal management and commitment to accountability and transparency by Charity Navigator, the country’s largest and most-utilized independent evaluator of charities.
Cure Alzheimer's Fund (CAF) welcomes two new Scientific Advisory Board (SAB) members...
Cure Alzheimer's Fund (CAF) welcomes two new Scientific Advisory Board (SAB) members: Marc Tessier-Lavigne, Ph.D., president of The Rockefeller University, and former CAF Research Consortium member Robert C. Malenka, M.D., Ph.D., of Stanford University.
Meet Cure Alzheimer’s Funded researcher, Giuseppina Tesco, M.D., Ph.D., assistant professor of neuroscience, Alzheimer’s Disease Research Laboratory, Department of Neuroscience, Tufts University School of Medicine
Meet Cure Alzheimer’s Funded researcher, Giuseppina Tesco, M.D., Ph.D., assistant professor of neuroscience, Alzheimer’s Disease Research Laboratory, Department of Neuroscience, Tufts University School of Medicine
TREM2: New candidate gene for AD
Rudy Tanzi, Chair, Cure Alzheimer's Fund Research Consortium comments here on the AP article appearing on this topic today:
Origins of Alzheimer's Increasingly Clear
Consensus among Alzheimer’s researchers about the origins of the disease is growing. Most, including members of Cure Alzheimer’s Fund Research Consortium, agree that a combination of factors, beginning with the excessive build-up of the peptide Abeta42 triggering the development of tau tangles, nerve cell death, and inflammation are all required for Alzheimer’s pathology.
